ID   AT2L2_HUMAN             Reviewed;         450 AA.
AC   Q8IUZ5; A8K7P6; B3KN36; D3DWP9; Q8WYS6; Q96HW8;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   12-APR-2017, entry version 134.
DE   RecName: Full=5-phosphohydroxy-L-lysine phospho-lyase;
DE            EC=4.2.3.134;
DE   AltName: Full=Alanine--glyoxylate aminotransferase 2-like 2;
GN   Name=PHYKPL; Synonyms=AGXT2L2; ORFNames=PP9286;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   VAL-437.
RC   TISSUE=Placenta, and Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, Muscle, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22241472; DOI=10.1074/jbc.M111.323485;
RA   Veiga-da-Cunha M., Hadi F., Balligand T., Stroobant V.,
RA   Van Schaftingen E.;
RT   "Molecular identification of hydroxylysine kinase and of
RT   ammoniophospholyases acting on 5-phosphohydroxy-L-lysine and
RT   phosphoethanolamine.";
RL   J. Biol. Chem. 287:7246-7255(2012).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANTS PHLU ARG-240 AND VAL-437.
RX   PubMed=23242558; DOI=10.1007/s10545-012-9568-9;
RA   Veiga-da-Cunha M., Verhoeven-Duif N.M., de Koning T.J., Duran M.,
RA   Dorland B., Van Schaftingen E.;
RT   "Mutations in the AGXT2L2 gene cause phosphohydroxylysinuria.";
RL   J. Inherit. Metab. Dis. 36:961-966(2013).
CC   -!- FUNCTION: Catalyzes the pyridoxal-phosphate-dependent breakdown of
CC       5-phosphohydroxy-L-lysine, converting it to ammonia, inorganic
CC       phosphate and 2-aminoadipate semialdehyde.
CC       {ECO:0000269|PubMed:22241472}.
CC   -!- CATALYTIC ACTIVITY: (5R)-5-phosphonooxy-L-lysine + H(2)O = (S)-2-
CC       amino-6-oxohexanoate + NH(3) + phosphate.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:22241472};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=16 uM for 5-phosphohydroxy-L-lysine (at 30 degrees Celsius)
CC         {ECO:0000269|PubMed:22241472};
CC         Vmax=256 nmol/min/mg enzyme {ECO:0000269|PubMed:22241472};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-751947, EBI-751947;
CC       Q9NUX5:POT1; NbExp=2; IntAct=EBI-751947, EBI-752420;
CC       O60763:USO1; NbExp=3; IntAct=EBI-751947, EBI-356164;
CC       Q08AM6:VAC14; NbExp=3; IntAct=EBI-751947, EBI-2107455;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IUZ5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IUZ5-2; Sequence=VSP_025585;
CC       Name=3;
CC         IsoId=Q8IUZ5-3; Sequence=VSP_025584;
CC   -!- DISEASE: Phosphohydroxylysinuria (PHLU) [MIM:615011]: A condition
CC       characterized by elevated phosphohydroxylysine in the urine. There
CC       is no clinical phenotype associated with this finding other than
CC       the urinary metabolites. {ECO:0000269|PubMed:23242558}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the class-III pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -!- CAUTION: Does not seem to possess aminotransferase activity.
CC       {ECO:0000305|PubMed:22241472}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF318375; AAL55882.1; -; mRNA.
DR   EMBL; AK023470; BAG51198.1; -; mRNA.
DR   EMBL; AK292061; BAF84750.1; -; mRNA.
DR   EMBL; AC136601; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC136632; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471165; EAW53836.1; -; Genomic_DNA.
DR   EMBL; CH471165; EAW53841.1; -; Genomic_DNA.
DR   EMBL; BC008009; AAH08009.1; -; mRNA.
DR   EMBL; BC037567; AAH37567.1; -; mRNA.
DR   EMBL; BC110335; AAI10336.1; -; mRNA.
DR   CCDS; CCDS4434.1; -. [Q8IUZ5-1]
DR   RefSeq; NP_001265275.1; NM_001278346.1.
DR   RefSeq; NP_699204.1; NM_153373.3. [Q8IUZ5-1]
DR   UniGene; Hs.248746; -.
DR   ProteinModelPortal; Q8IUZ5; -.
DR   SMR; Q8IUZ5; -.
DR   BioGrid; 124425; 7.
DR   IntAct; Q8IUZ5; 5.
DR   MINT; MINT-1441286; -.
DR   STRING; 9606.ENSP00000310978; -.
DR   DrugBank; DB00160; L-Alanine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   iPTMnet; Q8IUZ5; -.
DR   PhosphoSitePlus; Q8IUZ5; -.
DR   DMDM; 74750645; -.
DR   EPD; Q8IUZ5; -.
DR   MaxQB; Q8IUZ5; -.
DR   PaxDb; Q8IUZ5; -.
DR   PeptideAtlas; Q8IUZ5; -.
DR   PRIDE; Q8IUZ5; -.
DR   DNASU; 85007; -.
DR   Ensembl; ENST00000308158; ENSP00000310978; ENSG00000175309. [Q8IUZ5-1]
DR   GeneID; 85007; -.
DR   KEGG; hsa:85007; -.
DR   UCSC; uc003miz.5; human. [Q8IUZ5-1]
DR   CTD; 85007; -.
DR   DisGeNET; 85007; -.
DR   GeneCards; PHYKPL; -.
DR   H-InvDB; HIX0164247; -.
DR   HGNC; HGNC:28249; PHYKPL.
DR   HPA; HPA036461; -.
DR   HPA; HPA063608; -.
DR   MalaCards; PHYKPL; -.
DR   MIM; 614683; gene.
DR   MIM; 615011; phenotype.
DR   neXtProt; NX_Q8IUZ5; -.
DR   OpenTargets; ENSG00000175309; -.
DR   PharmGKB; PA162376015; -.
DR   eggNOG; KOG1403; Eukaryota.
DR   eggNOG; COG0160; LUCA.
DR   GeneTree; ENSGT00530000062907; -.
DR   HOGENOM; HOG000020206; -.
DR   HOVERGEN; HBG004196; -.
DR   InParanoid; Q8IUZ5; -.
DR   KO; K18202; -.
DR   OMA; LIGQSCR; -.
DR   OrthoDB; EOG091G08ZM; -.
DR   PhylomeDB; Q8IUZ5; -.
DR   TreeFam; TF320468; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-71064; Lysine catabolism.
DR   GenomeRNAi; 85007; -.
DR   PRO; PR:Q8IUZ5; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000175309; -.
DR   CleanEx; HS_AGXT2L2; -.
DR   ExpressionAtlas; Q8IUZ5; baseline and differential.
DR   Genevisible; Q8IUZ5; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0008453; F:alanine-glyoxylate transaminase activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0016829; F:lyase activity; TAS:Reactome.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IBA:GO_Central.
DR   GO; GO:0030574; P:collagen catabolic process; TAS:Reactome.
DR   GO; GO:0006554; P:lysine catabolic process; TAS:Reactome.
DR   CDD; cd00610; OAT_like; 1.
DR   Gene3D; 3.90.1150.10; -; 2.
DR   InterPro; IPR005814; Aminotrans_3.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   Pfam; PF00202; Aminotran_3; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   PROSITE; PS00600; AA_TRANSFER_CLASS_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Aminotransferase; Complete proteome;
KW   Disease mutation; Lyase; Mitochondrion; Polymorphism;
KW   Pyridoxal phosphate; Reference proteome; Transferase.
FT   CHAIN         1    450       5-phosphohydroxy-L-lysine phospho-lyase.
FT                                /FTId=PRO_0000287667.
FT   MOD_RES     278    278       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1    343       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15498874}.
FT                                /FTId=VSP_025585.
FT   VAR_SEQ       1    275       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025584.
FT   VARIANT     126    126       H -> R (in dbSNP:rs7707147).
FT                                /FTId=VAR_048233.
FT   VARIANT     240    240       G -> R (in PHLU; dbSNP:rs201105857).
FT                                {ECO:0000269|PubMed:23242558}.
FT                                /FTId=VAR_069543.
FT   VARIANT     437    437       E -> V (in PHLU; dbSNP:rs142181517).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:23242558}.
FT                                /FTId=VAR_069544.
SQ   SEQUENCE   450 AA;  49711 MW;  5EB28A6BDD44C429 CRC64;
     MAADQRPKAD TLALRQRLIS SSCRLFFPED PVKIVRAQGQ YMYDEQGAEY IDCISNVAHV
     GHCHPLVVQA AHEQNQVLNT NSRYLHDNIV DYAQRLSETL PEQLCVFYFL NSGSEANDLA
     LRLARHYTGH QDVVVLDHAY HGHLSSLIDI SPYKFRNLDG QKEWVHVAPL PDTYRGPYRE
     DHPNPAMAYA NEVKRVVSSA QEKGRKIAAF FAESLPSVGG QIIPPAGYFS QVAEHIRKAG
     GVFVADEIQV GFGRVGKHFW AFQLQGKDFV PDIVTMGKSI GNGHPVACVA ATQPVARAFE
     ATGVEYFNTF GGSPVSCAVG LAVLNVLEKE QLQDHATSVG SFLMQLLGQQ KIKHPIVGDV
     RGVGLFIGVD LIKDEATRTP ATEEAAYLVS RLKENYVLLS TDGPGRNILK FKPPMCFSLD
     NARQVVAKLD AILTDMEEKV RSCETLRLQP
//
